This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Identify buffer targets, automate savings, and simulate scenarios to ensure your budget remains steady when unexpected costs arise.
19,303 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Authorities have begun evacuations from a hantavirus-hit cruise, with American passengers slated for quarantine in Ne...
A gas explosion at a Shanxi coal mine has killed 82 and injured 120+, triggering a national safety probe as regulator...
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
In a pivotal moment, kevin warsh debuts chair at the Federal Reserve, with policymakers keeping the federal funds rat...
Maritime officials say the southern Hormuz corridor remains open despite Iran’s blockade claim, keeping a key energy ...
Trump endorses ethics restrictions tied to the CLARITY Act, handing Democrats a pivotal decision on crypto oversight....
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...
The S&P 500 dropped around 1.5% as crude surged on geopolitical worries, reviving inflation fears and tempering expec...
Investors brace for potential disruption as Trump-Iran brinkmanship over the Strait of Hormuz raises the risk of oil ...
Sharplink's 2026 earnings path hinges on user growth, margins, and regulatory resilience. This guide breaks down the ...